1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market


4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Market Outlook

5.1. Key Industry Developments

5.2. Regulatory Scenario

5.3. Reimbursement Scenario

5.4. Key Mergers & Acquisitions

5.5. Technological Advancements


6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product

6.1. Introduction & Definition

6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

6.2.1. Embolization Coils

6.2.2. Liquid Embolic Systems

6.2.3. Flow Diversion Stents

6.2.4. Aneurysm Clips

6.2.5. Others

6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product


7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment

7.1. Introduction & Definition

7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

7.2.1. Ischemic Stroke Solution

7.2.2. Hemorrhagic Stroke Solution

7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment


8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication

8.1. Introduction

8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

8.2.1. Brain Aneurysms

8.2.2. Arteriovenous Malformation (AVM)

8.2.3. Others

8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication


9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User

9.1. Introduction

9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

9.2.1. Hospitals

9.2.2. Ambulatory Surgery Centers

9.2.3. Specialty Clinics

9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User


10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region

10.1. Introduction

10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017–2027

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region


11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

11.1. Introduction

11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

11.2.1. Embolization Coils

11.2.2. Liquid Embolic Systems

11.2.3. Flow Diversion Stents

11.2.4. Aneurysm Clips

11.2.5. Others

11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

11.3.1. Ischemic Stroke Solution

11.3.2. Hemorrhagic Stroke Solution

11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

11.4.1. Brain Aneurysms

11.4.2. Arteriovenous Malformation (AVM)

11.4.3. Others

11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

11.5.1. Hospitals

11.5.2. Ambulatory Surgery Centers

11.5.3. Specialty Clinics

11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

11.7.1. By Product

11.7.2. By Treatment

11.7.3. By Indication

11.7.4. By End User

11.7.5. By Country/Sub-region


12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

12.1. Introduction

12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

12.2.1. Embolization Coils

12.2.2. Liquid Embolic Systems

12.2.3. Flow Diversion Stents

12.2.4. Aneurysm Clips

12.2.5. Others

12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

12.3.1. Ischemic Stroke Solution

12.3.2. Hemorrhagic Stroke Solution

12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

12.4.1. Brain Aneurysms

12.4.2. Arteriovenous Malformation (AVM)

12.4.3. Others

12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

12.5.1. Hospitals

12.5.2. Ambulatory Surgery Centers

12.5.3. Specialty Clinics

12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

12.7.1. By Product

12.7.2. By Treatment

12.7.3. By Indication

12.7.4. By End User

12.7.5. By Country/Sub-region

13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

13.1. Introduction

13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

13.2.1. Embolization Coils

13.2.2. Liquid Embolic Systems

13.2.3. Flow Diversion Stents

13.2.4. Aneurysm Clips

13.2.5. Others

13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

13.3.1. Ischemic Stroke Solution

13.3.2. Hemorrhagic Stroke Solution

13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

13.4.1. Brain Aneurysms

13.4.2. Arteriovenous Malformation (AVM)

13.4.3. Others

13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

13.5.1. Hospitals

13.5.2. Ambulatory Surgery Centers

13.5.3. Specialty Clinics

13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

13.6.1. Japan

13.6.2. China

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

13.7.1. By Product

13.7.2. By Treatment

13.7.3. By Indication

13.7.4. By End User

13.7.5. By Country/Sub-region

14. Latin America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

14.1. Introduction

14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

14.2.1. Embolization Coils

14.2.2. Liquid Embolic Systems

14.2.3. Flow Diversion Stents

14.2.4. Aneurysm Clips

14.2.5. Others

14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

14.3.1. Ischemic Stroke Solution

14.3.2. Hemorrhagic Stroke Solution

14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

14.4.1. Brain Aneurysms

14.4.2. Arteriovenous Malformation (AVM)

14.4.3. Others

14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

14.5.1. Hospitals

14.5.2. Ambulatory Surgery Centers

14.5.3. Specialty Clinics

14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

14.7.1. By Product

14.7.2. By Treatment

14.7.3. By Indication

14.7.4. By End User

14.7.5. By Country/Sub-region


15. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast

15.1. Introduction

15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

15.2.1. Embolization Coils

15.2.2. Liquid Embolic Systems

15.2.3. Flow Diversion Stents

15.2.4. Aneurysm Clips

15.2.5. Others

15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

15.3.1. Ischemic Stroke Solution

15.3.2. Hemorrhagic Stroke Solution

15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

15.4.1. Brain Aneurysms

15.4.2. Arteriovenous Malformation (AVM)

15.4.3. Others

15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

15.5.1. Hospitals

15.5.2. Ambulatory Surgery Centers

15.5.3. Specialty Clinics

15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

15.7.1. By Product

15.7.2. By Treatment

15.7.3. By Indication

15.7.4. By End User

15.7.5. By Country/Sub-region


16. Competition Landscape

16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)

16.2. Company Profiles

16.2.1. Medtronic plc

16.2.1.1. Company Description

16.2.1.2. Business Overview

16.2.1.3. Financial Overview

16.2.1.4. Strategic Overview

16.2.1.5. SWOT Analysis

16.2.2. Stryker Corporation

16.2.2.1. Company Description

16.2.2.2. Business Overview

16.2.2.3. Financial Overview

16.2.2.4. Strategic Overview

16.2.2.5. SWOT Analysis

16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)

16.2.3.1. Company Description

16.2.3.2. Business Overview

16.2.3.3. Financial Overview

16.2.3.4. Strategic Overview

16.2.3.5. SWOT Analysis

16.2.4. B.Braun Melsungen AG

16.2.4.1. Company Description

16.2.4.2. Business Overview

16.2.4.3. Financial Overview

16.2.4.4. Strategic Overview

16.2.4.5. SWOT Analysis

16.2.5. Penumbra, Inc.

16.2.5.1. Company Description

16.2.5.2. Business Overview

16.2.5.3. Financial Overview

16.2.5.4. Strategic Overview

16.2.5.5. SWOT Analysis

16.2.6. Acandis GmbH

16.2.6.1. Company Description

16.2.6.2. Business Overview

16.2.6.3. Financial Overview

16.2.6.4. Strategic Overview

16.2.6.5. SWOT Analysis

16.2.7. BALT EXTRUSION

16.2.7.1. Company Description

16.2.7.2. Business Overview

16.2.7.3. Financial Overview

16.2.7.4. Strategic Overview

16.2.7.5. SWOT Analysis

16.2.8. Terumo Medical Corporation

16.2.8.1. Company Description

16.2.8.2. Business Overview

16.2.8.3. Financial Overview

16.2.8.4. Strategic Overview

16.2.8.5. SWOT Analysis

16.2.9. Boston Scientific Corporation

16.2.9.1. Company Description

16.2.9.2. Business Overview

16.2.9.3. Financial Overview

16.2.9.4. Strategic Overview

16.2.9.5. SWOT Analysis

16.2.10. Spartan Micro, Inc.

16.2.10.1. Company Description

16.2.10.2. Business Overview

16.2.10.3. Financial Overview

16.2.10.4. Strategic Overview

16.2.10.5. SWOT Analysis